ADMA Biologics Inc (NASDAQ:ADMA)

9.15
Delayed Data
As of Mar 27
 -0.08 / -0.87%
Today’s Change
6.76
Today|||52-Week Range
14.00
-18.08%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 19.00, with a high estimate of 20.00 and a low estimate of 17.50. The median estimate represents a +107.65% increase from the last price of 9.15.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.38
Sales
$1.5M
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.66%
 
 
 
 
 
 
Growthannually -11.49%
 
 
 
 

Sales

Growthquarterly 0.57%
 
 
 
 
 
 
Growthannually 7.46%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account